These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chromosomal microarray analysis versus noninvasive prenatal testing in fetuses with increased nuchal translucency. Wang C, Tang J, Tong K, Huang D, Tu H, Zhu J. J Hum Genet; 2022 Sep; 67(9):533-539. PubMed ID: 35578003 [Abstract] [Full Text] [Related]
3. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype. Su L, Huang H, An G, Cai M, Wu X, Li Y, Xie X, Lin Y, Wang M, Xu L. Mol Genet Genomic Med; 2019 Aug; 7(8):e811. PubMed ID: 31209990 [Abstract] [Full Text] [Related]
4. Application of expanded noninvasive prenatal test in prenatal diagnosis of fetuses with increased nuchal translucency. Xie X, Zhou H, Zhao Q, Lu Y, Meng Y. J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6213-6218. PubMed ID: 34649482 [Abstract] [Full Text] [Related]
10. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency. Sinajon P, Chitayat D, Roifman M, Wasim S, Carmona S, Ryan G, Noor A, Kolomietz E, Chong K. Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076 [Abstract] [Full Text] [Related]
11. Nuchal translucency of 3.0-3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review. Petersen OB, Smith E, Van Opstal D, Polak M, Knapen MFCM, Diderich KEM, Bilardo CM, Arends LR, Vogel I, Srebniak MI. Acta Obstet Gynecol Scand; 2020 Jun; 99(6):765-774. PubMed ID: 32306377 [Abstract] [Full Text] [Related]
13. [Application of chromosomal microarray analysis in prenatal diagnosis of fetuses with increased nuchal translucency]. Ni M, Li J, Zhu X, Zhu Y, Gu L, Wu X, Yang Y. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct 10; 36(10):970-974. PubMed ID: 31598938 [Abstract] [Full Text] [Related]
15. When NIPT meets WES, prenatal diagnosticians face the dilemma: genetic etiological analysis of 2,328 cases of NT thickening and follow-up of pregnancy outcomes. Ji X, Li Q, Qi Y, Wang X, Ding H, Lu J, Zhang Y, Yin A. Front Genet; 2023 Oct 10; 14():1227724. PubMed ID: 37600658 [Abstract] [Full Text] [Related]
16. Application of chromosomal microarray in fetuses with increased nuchal translucency. Zhao XR, Gao L, Wu Y, Wang YL. J Matern Fetal Neonatal Med; 2020 May 10; 33(10):1749-1754. PubMed ID: 30688128 [Abstract] [Full Text] [Related]
17. Diagnostic yield of chromosomal microarray analysis in fetuses with isolated increased nuchal translucency: a French multicenter study. Egloff M, Hervé B, Quibel T, Jaillard S, Le Bouar G, Uguen K, Saliou AH, Valduga M, Perdriolle E, Coutton C, Coston AL, Coussement A, Anselem O, Missirian C, Bretelle F, Prieur F, Fanget C, Muti C, Jacquemot MC, Beneteau C, Le Vaillant C, Vekemans M, Salomon LJ, Vialard F, Malan V. Ultrasound Obstet Gynecol; 2018 Dec 10; 52(6):715-721. PubMed ID: 29027723 [Abstract] [Full Text] [Related]
19. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency? Miranda J, Paz Y Miño F, Borobio V, Badenas C, Rodriguez-Revenga L, Pauta M, Borrell A. Ultrasound Obstet Gynecol; 2020 May 10; 55(5):645-651. PubMed ID: 31301176 [Abstract] [Full Text] [Related]
20. [Comparison of results of prenatal diagnosis by different techniques for fetuses with increased nuchal translucency]. Dai W, Liu X, Ma X, Yu Z, Li H. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 May 10; 40(5):532-537. PubMed ID: 37102284 [Abstract] [Full Text] [Related] Page: [Next] [New Search]